LYON, France, April 8, 2009 -- (HSMN NewsFeed) -- EDAP TMS SA (NasdaqGM:EDAP ), the global leader in therapeutic ultrasound, announced today that the Association of Italian Urologists (AURO) has recommended High Intensity Focused Ultrasound (HIFU) as a standard of care for the treatment of prostate cancer as part of the Association's new guidelines on prostate cancer diagnosis and therapy.
The recommendation and updated guidelines on the use of HIFU for prostate cancer are based on the significant number of HIFU patients treated in Europe to date and on a comprehensive review of the current literature highlighting the positive clinical outcomes and acceptable follow-up.
Full article >> http://salesandmarketingnetwork.com/news_release.php?pipe=0000ac177000191&ID=2027769
Friday, April 10, 2009
EDAP Announces Association of Italian Urologists Recommends HIFU as a Standard of Care for Prostate Cancer Treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment